Busca un médico

Jeff W. Meeusen, Ph.D.

Publicaciones

  1. Churchill RA, Gochanour BR, Scott CG, Vasile VC, Rodeheffer RJ, Meeusen JW, Jaffe AS. Association of cardiac biomarkers with long-term cardiovascular events in a community cohort. Biomarkers. 2024 Jun; 29 (4):161-170 Epub 2024 Apr 26
    View PubMed
  2. Block DR, Lasho MA, Donato LJ, Meeusen JW. Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. Am J Clin Pathol. 2024 May 6 Epub 2024 May 06
    View PubMed
  3. Wang Q, Meeusen JW. Clinical Impacts of Implementing the 2021 Race-Free Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate. J Appl Lab Med. 2024 May 2; 9 (3):586-598
    View PubMed
  4. Jiao J, Bernard PE, Meeusen J, Militello L, El-Khoury JM. Glycerol Kinase Deficiency with Increased Triglycerides and Weight Gain: Pseudo or Real? Clin Chem. 2024 May 2; 70 (5):703-706
    View PubMed
  5. Seehusen KE, Remaley AT, Sampson M, Meeusen JW, Larson NB, Decker PA, Killian JM, Takahashi PY, Roger VL, Manemann SM, Lam R, Bielinski SJ. Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort. J Am Heart Assoc. 2024 Apr 16; 13 (8):e031878 Epub 2024 Apr 09
    View PubMed
  6. Coverdell TC, Sampson M, Zubiran R, Wolska A, Donato LJ, Meeusen JW, Jaffe AS, Remaley AT. An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation. Lipids Health Dis. 2024 Feb 8; 23 (1):43 Epub 2024 Feb 08
    View PubMed
  7. Sampson M, Wolska A, Meeusen JW, Otvos J, Remaley AT. The Sampson-NIH Equation Is the Preferred Calculation Method for LDL-C. Clin Chem 2024 Feb 7; 70 (2):399-402
    View PubMed
  8. Kelly, Andrew, Meeusen Jeffrey. Clinical Update: Ceramides As Novel Biomarkers of Cardiovascular Disease Risk The Journal for Nurse Practitioners. 2024; 20(1). Epub 2023 Dec 05.
  9. Kasozi RN, Meeusen JW, Lieske JC. Estimating glomerular filtration rate with new equations: can one size ever fit all? Crit Rev Clin Lab Sci. 2023 Nov; 60 (7):549-559 Epub 2023 June 01
    View PubMed
  10. Beunders R, Donato LJ, van Groenendael R, Arlt B, Carvalho-Wodarz C, Schulte J, Coolen AC, Lieske JC, Meeusen JW, Jaffe AS, Pickkers P. Assessing GFR With Proenkephalin. Kidney Int Rep. 2023 Nov; 8 (11):2345-2355 Epub 2023 Aug 19
    View PubMed
  11. Schwable Santamaria A, Grassi M, Meeusen JW, Lieske JC, Scott R, Robertson A, Schiffer E. Performance of Nuclear Magnetic Resonance-Based Estimated Glomerular Filtration Rate in a Real-World Setting. Bioengineering (Basel). 2023 Jun 13; 10 (6) Epub 2023 June 13
    View PubMed
  12. Stammler F, Derain-Dubourg L, Lemoine S, Meeusen JW, Dasari S, Lieske JC, Robertson A, Schiffer E. Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease. BMC Nephrol. 2023 Mar 31; 24 (1):83
    View PubMed
  13. Ramos P, Meeusen JW. Ceramide Risk Scores Can Bring Lipidomics to Clinical Medicine. Clin Chem 2022 Dec 6; 68 (12):1479-1480
    View PubMed
  14. Sampson M, Wolska A, Cole J, Zubiran R, Otvos JD, Meeusen JW, Donato LJ, Jaffe AS, Remaley AT. Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations. Biomedicines. 2022 Dec 6; 10 (12) Epub 2022 Dec 06
    View PubMed
  15. Fatica EM, Jenkins SM, Scott RJ, Block DR, Meeusen JW, Baumann NA, Saenger AK, Donato LJ. Short- and Long-Term Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol. J Appl Lab Med. 2022 Sep 1; 7 (5):1047-1061
    View PubMed
  16. Ramos P, Jenkins SM, Donato LJ, Hartman SJ, Saenger A, Baumann NA, Block DR, Jaffe AS, Meeusen JW. The Biological Variability of Plasma Ceramides in Healthy Subjects. J Appl Lab Med. 2022 Jun 30; 7(4):863-870.
    View PubMed
  17. Ramos PA, Meeusen JW. A more accessible lipid phenotype for predicting type 2 diabetes. Lancet Healthy Longev 2022 May; 3 (5):e312-e313 Epub 2022 May 04
    View PubMed
  18. Fuhrmann M, Schwaeble Santamaria A, Scott R, Meeusen JW, Fernandes M, Venz J, Rothe V, Stammler F, Ehrich J, Schiffer E. Analytical Validation of GFRNMR: A Blood-Based Multiple Biomarker Assay for Accurate Estimation of Glomerular Filtration Rate. Diagnostics (Basel). 2022 Apr 30; 12 (5)
    View PubMed
  19. Meeusen JW, Kasozi RN, Larson TS, Lieske JC. Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation. Clin Chem. 2022 Mar 31; 68 (4):534-539
    View PubMed
  20. Zheng W, Chilazi M, Park J, Sathiyakumar V, Donato LJ, Meeusen JW, Lazo M, Guallar E, Kulkarni KR, Jaffe AS, Santos RD, Toth PP, Jones SR, Martin SS. Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol. J Am Heart Assoc. 2022 Jan 18; 11 (2):e023136 Epub 2022 Jan 13
    View PubMed
  21. Sampson M, Wolska A, Meeusen JW, Donato LJ, Jaffe AS, Remaley AT. Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol. Front Genet. 2022; 13:935257. Epub 2022 Jul 14.
    View PubMed
  22. Meeusen JW, Stammler F, Dasari S, Schiffer E, Lieske JC. Serum myo-inositol and valine improve metabolomic-based estimated glomerular filtration rate among kidney transplant recipients. Front Med (Lausanne). 2022; 9:988989 Epub 2022 Nov 17
    View PubMed
  23. Stammler F, Grassi M, Meeusen JW, Lieske JC, Dasari S, Dubourg L, Lemoine S, Ehrich J, Schiffer E. Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C. Diagnostics (Basel). 2021 Dec 7; 11 (12) Epub 2021 Dec 07
    View PubMed
  24. Meeusen JW, Amer H, Lieske JC. Has Noninvasive Kidney Transplant Surveillance Finally Arrived? Clin Chem. 2021 Aug 5; 67 (8):1047-1049
    View PubMed
  25. Vasile VC, Meeusen JW, Medina Inojosa JR, Donato LJ, Scott CG, Hyun MS, Vinciguerra M, Rodeheffer RR, Lopez-Jimenez F, Jaffe AS. Ceramide Scores Predict Cardiovascular Risk in the Community. Arterioscler Thromb Vasc Biol. 2021 Apr; 41 (4):1558-1569 Epub 2021 Feb 18
    View PubMed
  26. Fatica EM, Meeusen JW, Vasile VC, Jaffe AS, Donato LJ. Corrigendum to "Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation" [Clin. Biochem. 86 (2020) 45-51]. Clin Biochem. 2021 Feb; 88:56-57 Epub 2021 Jan 19
    View PubMed
  27. Fatica EM, Meeusen JW, Vasile VC, Jaffe AS, Donato LJ. Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation. Clin Biochem. 2020 Dec; 86:45-51 Epub 2020 Sept 28
    View PubMed
  28. Meeusen JW, Donato LJ, Kopecky SL, Vasile VC, Jaffe AS, Laaksonen R. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clin Chim Acta. 2020 Dec; 511:138-142 Epub 2020 Oct 12
    View PubMed
  29. Ye Q, Svatikova A, Meeusen JW, Kludtke EL, Kopecky SL. Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Plasma Ceramide Levels. Am J Cardiol. 2020 Aug 1; 128:163-167 Epub 2020 May 15
    View PubMed
  30. Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, Sethi A, Fleming JK, Otvos JD, Meeusen JW, Delaney SR, Jaffe AS, Shamburek R, Amar M, Remaley AT. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020 May 1; 5 (5):540-548
    View PubMed
  31. El-Khoury JM, Remaley AT, Nordestgaard BG, Kaufman HW, Mora S, Cao J, Meeusen JW. Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL. Clin Chem. 2019 Dec; 65 (12):1487-1492 Epub 2019 Nov 07
    View PubMed
  32. Meeusen JW. The Heart Attack Cure: Vaccinating Against Cardiovascular Disease. Clin Chem 2018 Sep 1; 64 (9):1412
    View PubMed
  33. Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS. Plasma Ceramides. Arterioscler Thromb Vasc Biol. 2018 Aug; 38 (8):1933-1939
    View PubMed
  34. Donato LJ, Meeusen JW, Lieske JC, Bergmann D, Sparwasser A, Jaffe AS. Analytical performance of an immunoassay to measure proenkephalin. Clin Biochem. 2018 Aug; 58:72-77 Epub 2018 May 18
    View PubMed
  35. Meeusen JW. Apolipoprotein B or Low-Density Lipoprotein Cholesterol: Is It Time for a Twenty-First-Century Lipid Marker? Clin Chem. 2018 Jun 1; 64 (6):984-985
    View PubMed
  36. Donato LJ, Lueke A, Kenyon SM, Meeusen JW, Camilleri M. Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. Clin Biochem. 2018 Feb; 52:106-111 Epub 2017 Oct 16
    View PubMed
  37. Whelton SP, Meeusen JW, Donato LJ, Jaffe AS, Saenger A, Sokoll LJ, Blumenthal RS, Jones SR, Martin SS. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method. J Clin Lipidol. 2017 Jul - Aug; 11 (4):1065-1072 Epub 2017 June 01
    View PubMed
  38. Sepiashvili L, Dahl AR, Meeusen JW, Loftus CG, Donato LJ. A Man with Recurrent Ascites after Laparoscopic Cholecystectomy. Clin Chem. 2017 Jul; 63 (7):1199-1202
    View PubMed
  39. Meeusen JW, Donato LJ, Jaffe AS. Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes. Curr Cardiol Rep. 2017 Jun; 19 (6):48
    View PubMed
  40. Donato LJ, Meeusen JW, Jenkins SM, Hartman SJ, Saenger AK, Baumann NA, Block DR, Jaffe AS. Biological variability of lipoprotein-associated phospholipase A2 activity in healthy individuals. Clin Biochem. 2017 Apr; 50 (6):347-349 Epub 2016 Nov 25
    View PubMed
  41. Keddis MT, El-Zoghby Z, Kaplan B, Meeusen JW, Donato LJ, Cosio FG, Steidley DE. Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates. PLoS One. 2017; 12 (7):e0181123 Epub 2017 July 13
    View PubMed
  42. Meeusen JW. Spotlight on Laboratory Medicine: A Call for Reflections. J Appl Lab Med. 2017 Jan 1; 1 (4):462-463
    View PubMed
  43. Lueke AJ, Meeusen JW, Donato LJ, Gray AV, Butterfield JH, Saenger AK. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis. Clin Biochem. 2016 Sep; 49 (13-14):979-82 Epub 2016 Feb 18
    View PubMed
  44. Meeusen JW, Donato LJ, Jaffe AS. Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered? Curr Opin Lipidol. 2016 Aug; 27 (4):359-66
    View PubMed
  45. Divekar R, Hagan J, Rank M, Park M, Volcheck G, O'Brien E, Meeusen J, Kita H, Butterfield J. Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4 (4):665-70 Epub 2016 Apr 12
    View PubMed
  46. Donato LJ, Meeusen JW, Callanan H, Saenger AK, Jaffe AS. Advantages of the lipoprotein-associated phospholipase A2 activity assay. Clin Biochem. 2016 Jan; 49: (1-2)172-5.
    View PubMed
  47. Meeusen JW, Johnson JN, Gray A, Wendt P, Jefferies JL, Jaffe AS, Donato LJ, Saenger AK. Soluble ST2 and galectin-3 in pediatric patients without heart failure. Clin Biochem. 2015 Dec; 48 (18):1337-40 Epub 2015 Aug 12
    View PubMed
  48. Meeusen JW, Rule AD, Voskoboev N, Baumann NA, Lieske JC. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. Clin Chem. 2015 Oct; 61 (10):1265-72 Epub 2015 Aug 03
    View PubMed
  49. Karon BS, Meeusen JW, Bryant SC. Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After Cardiovascular Surgery. J Diabetes Sci Technol. 2015 Aug 25; 10 (2):336-42
    View PubMed
  50. Meeusen JW, Snozek CL, Baumann NA, Jaffe AS, Saenger AK. Reliability of Calculated Low-Density Lipoprotein Cholesterol. Am J Cardiol. 2015 Aug 15; 116(4):538-40. Epub 2015 May 21.
    View PubMed
  51. Nowakowski AB, Meeusen JW, Menden H, Tomasiewicz H, Petering DH. Chemical-biological properties of zinc sensors TSQ and zinquin: formation of sensor-Zn-protein adducts versus Zn(Sensor)2 complexes Inorganic Chemistry. 2015; 54: (24)11637-47.
    View PubMed
  52. Meeusen JW, Lueke AJ, Jaffe AS, Saenger AK. Validation of a proposed novel equation for estimating LDL cholesterol. Clin Chem. 2014 Dec; 60 (12):1519-23 Epub 2014 Oct 21
    View PubMed
  53. Meeusen JW, Lieske JC. Looking for a better creatinine. Clin Chem. 2014 Aug; 60 (8):1036-9 Epub 2014 Feb 26
    View PubMed
  54. Meeusen JW, Haselkorn KE, Fryer JP, Kryzer TJ, Gibbons SJ, Xiao Y, Lennon VA. Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice. Neurogastroenterol Motil. 2013 Jan; 25 (1):84-8.e10 Epub 2012 Oct 17
    View PubMed
  55. Meeusen JW, Lennon VA, Klein CJ. Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG. Neurology. 2012 Oct 23; 79 (17):1824-5 Epub 2012 Oct 10
    View PubMed
  56. Meeusen JW, Nowakowski A, Petering DH. Reaction of metal-binding ligands with the zinc proteome: zinc sensors and N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine. Inorg Chem. 2012 Mar 19; 51: (6)3625-32.
    View PubMed
  57. Meeusen JW, Klein CJ, Pirko I, Haselkorn KE, Kryzer TJ, Pittock SJ, Lachance DH, Dyck PJ, Lennon VA. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012 Mar; 71 (3):417-26
    View PubMed
  58. Meeusen JW, Tomasiewicz H, Nowakowski A, Petering DH. TSQ (6-methoxy-8-p-toluenesulfonamido-quinoline), a common fluorescent sensor for cellular zinc, images zinc proteins. Inorg Chem. 2011 Aug 15; 50: (16)7563-73.
    View PubMed
  59. Namdarghanbari MA, Meeusen J, Bachowski G, Giebel N, Johnson J, Petering DH. Reaction of the zinc sensor FluoZin-3 with Zn(7)-metallothionein: Inquiry into the existence of a proposed weak binding site. J Inorg Biochem. 2010 Mar; 104: (3)224-31.
    View PubMed
  60. Zhu J, Meeusen J, Krezoski S, Petering DH. Reactivity of Zn-, Cd-, and apo-metallothionein with nitric oxide compounds: in vitro and cellular comparison. Chem Res Toxicol. 2010 Feb 15; 23: (2)422-31.
    View PubMed
  61. Rana U, Kothinti R, Meeusen J, Tabatabai NM, Krezoski S, Petering DH. Zinc binding ligands and cellular zinc trafficking: apo-metallothionein, glutathione, TPEN, proteomic zinc, and Zn-Sp1. J Inorg Biochem. 2008 Mar; 102: (3)489-99.
    View PubMed
  62. Petering DH, Zhu J, Krezoski S, Meeusen J, Kiekenbush C, Krull S, Specher T, Dughish M. Apo-metallothionein emerging as a major player in the cellular activities of metallothionein. Exp Biol Med (Maywood). 2006 Oct; 231: (9)1528-34.
    View PubMed
PST-20514332